Intermountain Blood and Marrow Transplant/Acute Leukemia Program — Salt Lake City, Utah

Intermountain Blood and Marrow Transplant/Acute Leukemia Program is a clinical research site located in Salt Lake City, Utah, United States 84143.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Intermountain Blood and Marrow Transplant/Acute Leukemia Program has participated in 1 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia.

Sponsors: Seagen Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Salt Lake City

Browse all research sites in Utah · View every site in Salt Lake City

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Intermountain Blood and Marrow Transplant/Acute Leukemia Program?

Intermountain Blood and Marrow Transplant/Acute Leukemia Program has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Intermountain Blood and Marrow Transplant/Acute Leukemia Program conducted?

Intermountain Blood and Marrow Transplant/Acute Leukemia Program has 1 clinical trials on record. Their work covers Acute Myeloid Leukemia.

Is Intermountain Blood and Marrow Transplant/Acute Leukemia Program accredited by Crixeo Clinical Trials?

Intermountain Blood and Marrow Transplant/Acute Leukemia Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Intermountain Blood and Marrow Transplant/Acute Leukemia Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.